Skip to main content

Vascular hemodynamics and blood pressure differences between young and older women

Abstract

Background

Cardiovascular disease is one of the main causes of death in the United States, and hypertension is a primary risk factor. Therefore, the primary causes of hypertension need to be identified so they may be addressed for treatment. The purpose of this study was to compare blood pressure with hemodynamic values and identify factors that may explain blood pressure differences between a cohort of healthy normotensive younger and older women.

Methods

Participants were 49 young (age: 33.8 ± 5.9) and 103 old (age: 65.8 ± 4) who were non-hypertensive, had no previous history of heart disease or type 2 diabetes, body mass index less than 30 kg/m2, normal electrocardiography response at rest and during exercise, nonsmokers, and no use of medications known to affect cardiovascular or metabolic function. Body composition measured by dual-energy X-ray absorptiometry. Hemodynamic values measured by non-invasive pulse wave velocity through radial artery tonometry. Markers of inflammation measured through blood sample analysis.

Results

Significant differences exist between young and old groups in %fat (P < 0.001), systolic blood pressure (SBP) (P = 0.001), large artery elasticity (P = 0.005), small artery elasticity (P < 0.001), systemic vascular resistance (P = 0.004), total vascular impedance (P < 0.001), estimated cardiac output (P < 0.001), and tumor necrosis factor-⍺ (TNF-⍺) (P < 0.001). Using ANCOVA the difference in SBP between age groups was no longer significant after adjusting for small artery elasticity (P < 0.001) and TNF-⍺ (P = 0.041).

Conclusions

These data demonstrate that blood pressure and vascular hemodynamic measures differ significantly between young and old women independent of body composition. Furthermore, these differences may be explained by the inflammation marker TNF-⍺ and/or small artery elasticity.

Background

Hypertension is a primary risk factor for cardiovascular disease (CVD) and even a slight increase in blood pressure can heighten the risk for developing CVD [1]. Arterial stiffness has been shown to be associated with CVD. Furthermore, it has been shown that functional impairment of the arterial wall can be detected well before symptoms of CVD are present [2, 3]. There are several studies that have also shown a potential link between endothelial dysfunction and arterial stiffness specifically in hypertensive individuals, which suggest that they may be used as a critical tool to evaluate the progression of CVD [4, 5]. The occurrence of arterial stiffness, hypertension, and related cardiovascular diseases is higher in aged populations as compared to younger counterparts [6]. It has been well documented that age may be a risk factor for hypertension and that the prevalence of high blood pressure increases as we age if left untreated [7,8,9]. Alternatively, previous studies have shown that in menopausal women with endothelial dysfunction, carotid arterial stiffness and epicardial fat thickness are associated with the menopausal transition being independent of age [10]. Thus, it is difficult to determine if high blood pressure and/or arterial stiffness in women is associated with aging, secondary comorbidities, obesity, systemic inflammation, inactivity, or other natural occurrences such as menopause. Therefore, it is important to determine whether central arterial stiffness is a cause or effect of elevated blood pressure [11].

CVD is known as a “silent killer” due to the asymptomatic development starting as early as the first decade of life, thus it is important for medical professionals to identify valid and reliable techniques to assess and track the progression of CVD [12]. Previous studies have shown that hypertension is associated with other cardiovascular risk factors such as arterial elasticity [13]. As mentioned before, similar studies have shown that arterial elasticity will decrease where endothelial dysfunction and hypertension will increase with age [5,6,7, 9, 11]. An important point to understand about this though, is that this progression may occur differently depending on an individual’s gender, race, or environment. Select studies on hypertension focus on middle-aged and older adult populations [14,15,16], but other research have demonstrated importance of studying children and young adults due to the increasingly higher prevalence of cardiovascular and metabolic disease risk factors in this population [17,18,19]. Evidence number of studies have shown associations between tumor necrosis factor-α (TNF-α), and arterial elasticity, arterial inflammation, and endothelial dysfunction [20,21,22,23]. Relationships exist between hypertension and age-related arterial stiffness in cohorts of men, and men and women together [1, 5,6,7, 9, 11], but few studies have been conducted on cohorts of women alone [10, 24, 25]. Women have a significantly higher prevalence of hypertension as compared to men and have less success in lowering blood pressure when treated pharmacologically which can confound studies on older adults [1, 9, 26].

Therefore, it is important to compare blood pressure with vascular hemodynamic values between younger and older women that are healthy and normotensive. Thus, the primary purpose of this study was to identify factors that may explain blood pressure differences between a cohort of healthy normotensive younger and older women. The result of which would identify if these blood pressure differences may be explained by differences in markers of inflammation, body composition, or arterial elasticity.

Methods

Participants

This is a secondary analysis of two studies designed to evaluate free living energy expenditure. This data analysis consisted of 49 females aged 21–46, and 103 females aged 60+. The two groups of females were divided into young and old groups based on age. Inclusion requirements for participants were non-hypertensive (systolic blood pressure [SBP] < 140 or diastolic blood pressure [DBP] < 90 mmHg), no previous history of heart disease or type 2 diabetes, normal electrocardiogram (EKG) response at rest and during exercise, nonsmokers, and no use of medications known to affect cardiovascular or metabolic function. Preliminary screening for study inclusion also included a physical examination, dual-energy X-ray absorptiometry, and a 12-lead EKG. Participants were excluded from the study if they were hypertensive or dual-energy X-ray absorptiometry assessment revealed osteoporosis. The study was approved by the Institutional Review Board for Human Use at the University of Alabama at Birmingham. All women provided informed consent prior to participating in the study.

Body composition

Body composition was measured by dual-energy X-ray absorptiometry (Prodigy; Lunar Radiation, Madison, WI). The scans were analyzed with the use of ADULT software, version 1.33 (Lunar Radiation).

Arterial elasticity evaluation

Hemodynamic values such as SBP and DBP, large artery elasticity (LAE), small artery elasticity (SAE), estimated cardiac output (ECO), systemic vascular resistance (SVR), and total vascular impedance (TVI) were all measured by non-invasive pulse wave velocity analysis through radial artery tonometry (HDI/Pulse Wave TM CR-2000, Hypertension Diagnostics, Eagan, MN). Participants were placed in the seated position, with a solid-state pressure transducer array (tonometer) placed over the radial artery of the dominant arm to record the pulse contour. The waveform from the tonometer was calibrated by the oscillometric method. Once a stable measurement was achieved, a 30 s analog tracing of the radial waveform was digitized at 200 samples per second. Before, during, and after the waveform assessment, an automated oscillatory blood pressure measurement was taken on the contralateral arm. The first maximum waveform observed represented the action of the arteries following cardiac ejection and reflects the large arteries, whereas the second rebound wave reflects compliance of the smaller arteries. SVR was calculated as the mean arterial pressure divided by the ECO. TVI was determined from the modified Windkessel model evaluated at the frequency of the measured heart rate at rest [20].

Markers of inflammation

Systemic inflammation was measured by serum levels of TNF-α, interleukin-6 (IL-6), and C-reactive protein (CRP) through blood sample analysis. TNF-α was analyzed using the high-sensitivity ELISA kit (Quantikine HSTA00C, R&D Systems, Minneapolis, MN). IL-6 was assayed using the high-sensitivity ELISA kit (Quantikine HS600B, R&D Systems). CRP was assayed with the high-sensitivity ELISA kit (030–9710 s, ALPCO, Windham, NH).

Statistical analysis

Data was analyzed using the Statistical Package for the Social Sciences (SPSS, version 26.0, Chicago, IL). Means and standard deviations for anthropomorphic and hemodynamic measures, LAE, SAE, SVR, TVI, ECO, and proinflammatory cytokine levels, CRP, TNF-⍺, and IL-6 were reported and assessed by one-way analysis of variance (ANOVA) with a significance value of P <  0.05. Simple Pearson correlations were also used to examine associations of weight, BMI, %fat, SBP and DBP, as well as LAE and SAE, SVR and TVI, ECO, and the proinflammatory cytokine levels CRP, TNF-⍺, and IL-6 for the young and old groups. An analysis of covariance (ANCOVA) was performed to explain differences between SBP and age with %fat, LAE, SAE, and levels of TNF-⍺, CRP, and IL-6.

Results

Differences between body composition, vascular measures, and markers of inflammation are presented in Table 1. Significant differences between young and old were found in %fat, SBP, LAE, SAE, SVR, TVI, ECO, and TNF-⍺ (P < 0.05). No significant differences were observed between the age groups in weight, height, BMI, DBP, CRP or IL-6.

Table 1 Mean ± standard deviation for total participants and comparing young and old

Results from ANCOVA are shown in Table 2. Model 1 shows the probability for SBP differences in SBP after adjusting for age. Models 2–7 demonstrate the ANCOVA for SBP after adjusting for age, and a third variable. These data demonstrate that SBP differences observed between young and old were independent of %fat, LAE, CRP, and IL-6. However, the age differences in SBP may be partly explained by differences in serum TNF-⍺ and/or SAE.

Table 2 Systolic blood pressure (SBP) models after adjusting for potential cofounders

Pearson correlation analysis between variables are shown in Table 3. For both the young and old groups combined, there was a positive association with BMI and SBP, DBP, ECO, and CRP. BMI was negatively associated with SVR (P < 0.05). SBP was positively associated with DBP, SVR, and TVI, while an inverse association was found between SBP and LAE and SAE (P < 0.05). LAE and SAE were positively associated with ECO, and inversely associated with SVR and TVI (P < 0.05). TNF-⍺ was positively associated with %fat, SBP, SVR and TVI, but an inverse association was seen between TNF-⍺ and LAE, SAE, and ECO (P < 0.05).

Table 3 Pearson correlation table total (young and old)

Tables 4 and 5 represent the correlation table for young participants and older participants respectively. In the older group BMI was positively associated with DBP and SAE while an inverse association was seen between BMI and LAE and SVR (P < 0.05). BMI was not seen to have these same associations in the young group. SBP was negatively associated with LAE and SAE (P < 0.05) in the old group but this relationship was only seen between SBP and LAE in the young group. %Fat was positively associated with CRP in the young group, while %fat was positively associated with IL-6 in the older group (P < 0.05). TNF-⍺ was significant with SBP, DBP, LAE, SVR, and TVI in the older group. This significance was not seen in the young group suggesting that inflammation may have a greater affect in the older population.

Table 4 Pearson correlation table young
Table 5 Pearson correlation table old

Discussion

Due to the rise in prevalence of hypertension in the older population [6], and the relationship that is present between hypertension and arterial stiffness [12], the purpose of this study was to compare blood pressure with hemodynamic values of young and old normotensive participants to try and identify potential factors that predict the onset of developing hypertension and other CVDs. Factors that may prevent or treat hypertension are becoming increasingly important due to the prevalence of hypertension rising rapidly throughout the aging population [1] and limited societal awareness and response [7]. The primary findings of the study were that blood pressure and vascular hemodynamic measures differ between young and old women independent of body composition. Additionally, blood pressure differences between age groups were not explained by differences in LAE, CRP, or IL-6. However, these differences were partially explained by differences in SAE and TNF-⍺. Overall, these findings suggest that systemic inflammation as well as small arterial elasticity differences between younger and older healthy normotensive women may explain some age-related differences in blood pressure.

Studies have shown body composition measures to be strong predictors of arterial stiffness in young adults [17] and a regression in arterial stiffness has been seen with weight loss in both obese and nonobese individuals [18]. Participants for this study were matched for height and weight, so that BMI would not confound blood pressure measures. Participants were also excluded if they had osteoporosis. Thus, no significant differences were seen in height, weight or BMI, between the young and older participants. There was, however, a significant difference in %fat observed between the two groups. It is known that aging is associated with a shift of fat from the periphery to a more visceral fat distribution, though less is known about why this shift in fat distribution occurs [27]. This could explain the higher prevalence of body fat in the older group. This study saw that age related differences in blood pressure were independent of %fat, but since body fat percentage is associated with systemic inflammation [27], this could be one reason why we see increased TNF-⍺ levels. Higher %fat could equate to higher inflammation thus resulting in the higher SBP in the older group. More research is needed to assess if this increase in body fat is responsible for increased inflammation.

The ability of the arteries to perform properly and maintain regular blood flow and pressure can be hindered due to aging or other factors such as kidney disease, diabetes, atherosclerosis [28, 29] or hormonal changes during pregnancy or menopause [30]. Significant differences in arterial elasticity were seen between the young and old participants, and analysis of covariance showed that age differences in blood pressure could possibly be explained by SAE but not by LAE. This difference in arterial elasticity between the groups could partially be explained by increases in inflammation, which is known to decrease elasticity and affect endothelial health [16, 19]. This increased inflammation could be what causes SAE to explain age related differences in blood pressure in this study while LAE does not. Previous research has also shown that females develop higher distensability in their arteries while males develop stiffer arteries post puberty [31], this could explain some gender differences that are present with blood pressure [32]. Further research should look at the relationship to determine why smaller arteries may be affected by inflammation more than larger arteries and also further explore the gender differences present in blood pressure and arterial elasticity and distensability.

TNF-⍺, IL-6, and CRP have all been shown to be associated with CVD, and of those, TNF-⍺ has been shown to be the most correlated with arterial elasticity, vascular resistance, and blood pressure [20]. Of the three proinflammatory cytokines observed in this study, TNF-⍺ may explain age differences in blood pressure while CRP and IL-6 remained independent of age differences. This increase in inflammation, brought on by age or other factors such as an increase in body fat, could also result in the stiffening of arteries leading to cardiovascular or metabolic disease [15, 33]. Correlations with levels of TNF-⍺ and blood pressure were only seen in the older group. This could be due to the younger group being overall healthier and simply not having significant inflammation present.

The association between aging and blood pressure is complex. It is well known that aging [7,8,9] and other factors such as excess food intake [18, 33], shift in fat distribution [27], and lack of exercise [14], affect vascular hemodynamics but what are less known are factors that decrease this progression. This emphasizes the importance of studies with the goal of continuing to learn about this association and ways to decrease the prevalence of hypertension [29]. Previous studies have shown that exercise could be a factor that decreases the progression of hypertension. Aerobic exercise has been shown to elicit an increase in central aortic distensibility while resistance exercise may produce vasodialators not present after aerobic exercise [34, 35], but less it known about why this takes place. The present study suggests that increased TNF-⍺ and decreased SAE in older women could be a main contributing factor in the increase in SBP. An age-related increase in visceral fat over time is also known to contribute to an increase in inflammation [27], which then can lead to reduced small artery health. This decreased arterial health can then lead to an increase in blood pressure and may be the cause of cardiovascular or metabolic diseases in older women who are not overweight or obese. Because of this, it is possible that systemic inflammation and arterial elasticity differences between younger and older women, who are relatively matched in body composition, might explain the differences in blood pressure measures.

Overall strengths of this study include 1) strict inclusion requirements, 2) a large population size of young (n = 49) and old (n = 103) women, and 3) the use of state-of-the-art methods to assess body composition, hemodynamic measures, and inflammation markers. This study also provides clinical significance for the development of gender specific hypertension intervention. As previously stated, to the authors knowledge this is one of the first studies to look at differences in blood pressure and vascular measures in women alone. This study offers insight for health professionals to better monitor hypertension emergence in women by detecting the above mentioned risk factors early. The primary limitation of this study was the lack of aerobic fitness level inclusion, which could play a role in the prevalence of inflammation and arterial elasticity. Future research would be needed to investigate the relationship between fitness levels, systemic inflammation, and blood pressure differences between younger and older women.

Conclusions

These data demonstrate that blood pressure and vascular hemodynamic measures differ between young and old women independent of body composition. These differences may be at least partially explained by the inflammatory marker TNF-⍺ and SAE. Therefore, monitoring of these values in women as they age may help to detect the risk for emergence of hypertension.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

CRP:

C-reactive protein

CVD:

Cardiovascular disease

DBP:

Diastolic blood pressure

ECO:

Estimated cardiac output

EKG:

Electrocardiogram

IL-6:

Interleukin-6

LAE:

Large artery elasticity

SAE:

Small artery elasticity

SBP:

Systolic blood pressure

SVR:

Systemic vascular resistance

TNF-α:

Tumor necrosis factor-α

TVI:

Total vascular impedance

References

  1. 1.

    Lacruz ME, Kluttig A, Hartwig S, Löer M, Tiller D, Greiser KH, et al. Prevalence and incidence of hypertension in the general adult population: results of the CARLA-cohort study. Medicine (Baltimore). 2015;94:e952.

    Article  Google Scholar 

  2. 2.

    Rosenberg AJ, Lane-Cordova AD, Wee SO, White DW, Hilgenkamp TI, Fernhall B, et al. Healthy aging and carotid performance: strain measures and β-stiffness index. Hypertens Res. 2018;41:748–55.

    Article  Google Scholar 

  3. 3.

    Ogola BO, Zimmerman MA, Clark GL, Abshire CM, Gentry KM, Miller KS, et al. New insights into arterial stiffening: does sex matter? Am J Physiol Heart Circ Physiol. 2018;315:H1073–87.

    CAS  Article  Google Scholar 

  4. 4.

    Murkamilov IT, Sabirov IS, Fomin VV, Yusupov FA. Endothelial dysfunction and arterial wall stiffness: new targets in diabetic nephropathy. Ter Arkh. 2017;89:87–94.

    CAS  Article  Google Scholar 

  5. 5.

    Tomiyama H, Ishizu T, Kohro T, Matsumoto C, Higashi Y, Takase B, et al. Longitudinal association among endothelial function, arterial stiffness and subclinical organ damage in hypertension. Int J Cardiol. 2018;253:161–6.

    Article  Google Scholar 

  6. 6.

    Sun Z. Aging, arterial stiffness, and hypertension. Hypertension. 2015;65:252–6.

    CAS  Article  Google Scholar 

  7. 7.

    Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens. 2004;18:545–51.

    CAS  Article  Google Scholar 

  8. 8.

    Ooi HH, Coleman PL, Duggan J, O'Meara YM. Treatment of hypertension in the elderly. Curr Opin Nephrol Hypertens. 1997;6:504–9.

    CAS  Article  Google Scholar 

  9. 9.

    McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci. 2009;64:256–63.

    Article  Google Scholar 

  10. 10.

    Cabrera-Rego JO, Navarro-Despaigne D, Staroushik-Morel L, Diaz-Reyes K, Lima-Martinez MM, Iacobellis G. Association between endothelial dysfunction, epicardial fat and subclinical atherosclerosis during menopause. Clin Investig Arterioscler. 2018;30:21–7.

    PubMed  Google Scholar 

  11. 11.

    Alghatrif M, Lakatta EG. The conundrum of arterial stiffness, elevated blood pressure, and aging. Curr Hypertens Rep. 2015;17:12.

    Article  Google Scholar 

  12. 12.

    Stoner L, Young JM, Fryer S. Assessments of arterial stiffness and endothelial function using pulse wave analysis. Int J Vasc Med. 2012;2012:903107.

    PubMed  PubMed Central  Google Scholar 

  13. 13.

    Mikael LR, Paiva AM, Gomes MM, Sousa AL, Jardim PC, Vitorino PV, et al. Vascular aging and arterial stiffness. Arq Bras Cardiol. 2017;109:253–8.

    PubMed  PubMed Central  Google Scholar 

  14. 14.

    Vaitkevicius PV, Fleg JL, Engel JH, O’Connor FC, Wright JG, Lakatta LE, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation. 1993;88:1456–62.

    CAS  Article  Google Scholar 

  15. 15.

    Sutton-Tyrrell K, Najjar SS, Boudreau RM, Venkitachalam L, Kupelian V, Simonsick EM, et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 2005;111:3384–90.

    Article  Google Scholar 

  16. 16.

    McEniery CM, Wallace S, Mackenzie IS, McDonnell B, Yasmin NDE, et al. Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans. Hypertension. 2006;48:602–8.

    CAS  Article  Google Scholar 

  17. 17.

    Wildman RP, Farhat GN, Patel AS, Mackey RH, Brockwell S, Thompson T, et al. Weight change is associated with change in arterial stiffness among healthy young adults. Hypertension. 2005;45:187–92.

    CAS  Article  Google Scholar 

  18. 18.

    Fernberg U, Roodt JO, Fernström M, Hurtig-Wennlöf A. Body composition is a strong predictor of local carotid stiffness in Swedish, young adults – the cross-sectional lifestyle, biomarkers, and atherosclerosis study. BMC Cardiovasc Disord. 2019;19:205.

    Article  Google Scholar 

  19. 19.

    Martin H, Hu J, Gennser G, Norman M. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birthweight. Circulation. 2000;102:2739–44.

    CAS  Article  Google Scholar 

  20. 20.

    Fisher G, Hunter GR, Glasser SP. Associations between arterial elasticity and markers of inflammation in healthy older women. J Gerontol A Biol Sci Med Sci. 2013;68:382–8.

    CAS  Article  Google Scholar 

  21. 21.

    Hayek SS, Neuman R, Kavtaradze N, Sher S, Jones D, Li Q, et al. Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis. Int J Cardiol. 2015;182:387–9.

    Article  Google Scholar 

  22. 22.

    Moreau KL, Deane KD, Meditz AL, Kohrt WM. Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Atherosclerosis. 2013;230:390–6.

    CAS  Article  Google Scholar 

  23. 23.

    Barbaro NR, de Araujo TM, Tanus-Santos JE, Anhe GF, Fontana V, Moreno H. Vascular damage in resistant hypertension: TNF-alpha inhibition effects on endothelial cells. Biomed Res Int. 2015;2015:631594.

    Article  Google Scholar 

  24. 24.

    Georgiopoulos G, Lambrinoudaki I, Athanasouli F, Armeni E, Koliviras A, Augoulea A, et al. Prolactin as a predictor of endothelial dysfunction and arterial stiffness progression in menopause. J Hum Hypertens. 2017;31:520–4.

    CAS  Article  Google Scholar 

  25. 25.

    Hunter GR, Neumeier WH, Bickel CS, McCarthy JP, Fisher G, Chandler-Laney PC, et al. Arterial elasticity, strength, fatigue, and endurance in older women. Biomed Res Int. 2014;2014:501754.

    Article  Google Scholar 

  26. 26.

    Rizzo M, Corrado E, Coppola G, Muratori I, Novo G, Novo S. Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. Coron Artery Dis. 2009;20:15–20.

    Article  Google Scholar 

  27. 27.

    Hunter GR, Gower BA, Kane BL. Age related shift in visceral fat. Int J Body Compos Res. 2010;8:103–8.

    PubMed  PubMed Central  Google Scholar 

  28. 28.

    Covic A, Siriopol D. Pulse wave velocity ratio the new “gold standard” for measuring arterial stiffness. Hypertension. 2015;65:289–90.

    CAS  Article  Google Scholar 

  29. 29.

    Townsend RR, Wilkinson IB, Schiffrin EL, Avolio AP, Chirinos JA, Cockcroft JR, et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension. 2015;66:698–722.

    CAS  Article  Google Scholar 

  30. 30.

    Robb AO, Mills NL, Din JN, Smith IB, Paterson F, Newby DE, et al. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension. 2009;53:952–8.

    CAS  Article  Google Scholar 

  31. 31.

    Ahimastos AA, Formosa M, Dart AM, Kingwell BA. Gender differences in large artery stiffness pre- and post-puberty. J Clin Endocrinol Metab. 2003;88:5375–80.

    CAS  Article  Google Scholar 

  32. 32.

    van der Heijden-Spek JJ, Staessen JA, Fagard RH, Hoeks AP, Boudier HA, van Bortel LM. Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension. 2000;35:637–42.

    Article  Google Scholar 

  33. 33.

    Strasser B, Arvandi M, Pasha EP, Haley AP, Stanforth P, Tanaka H. Abdominal obesity is associated with arterial stiffness in middle-aged adults. Nutr Metab Cardiovasc Dis. 2015;25:495–502.

    CAS  Article  Google Scholar 

  34. 34.

    Hawkins M, Gabriel KP, Cooper J, Storti KL, Sutton-Tyrrell K, Kriska A. The impact of change in physical activity on change in arterial stiffness in overweight or obese sedentary young adults. Vasc Med. 2014;19:257–63.

    Article  Google Scholar 

  35. 35.

    Collier SR, Diggle MD, Heffernan KS, Kelly EE, Tobin MM, Fernhall B. Changes in arterial distensibility and flow-mediated dilation after acute resistance vs. aerobic exercise. J Strength Cond Res. 2010;24:2846–52.

    Article  Google Scholar 

Download references

Acknowledgments

The authors thank the volunteers for their participation and acknowledge the staff of the UAB Core Laboratories (NORC, DRC, and CCTS) for their involvement in this study.

Funding

US National Institutes of Health: R01AG27084-04S1, R01DK049779, P30DK56336, P60DK079626, and UL1RR025777.

Author information

Affiliations

Authors

Contributions

GH and GF had full access to all data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: GH and GF. Analysis and interpretation of data: All authors. Drafting of the manuscript: BB and GF. Critical revision the manuscript for intellectual content: All authors. Read and approved the final manuscript: All authors. Obtained funding: GH.

Corresponding author

Correspondence to Brantley K. Ballenger.

Ethics declarations

Ethics approval and consent to participate

The study was approved by the Institutional Review Board for Human Use at the University of Alabama at Birmingham; IRB-050820002, IRB-990728001. All women provided informed consent prior to participating in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ballenger, B.K., Hunter, G.R. & Fisher, G. Vascular hemodynamics and blood pressure differences between young and older women. Clin Hypertens 27, 25 (2021). https://doi.org/10.1186/s40885-021-00181-3

Download citation

Keywords

  • Blood pressure
  • Inflammation
  • Hemodynamics
  • Arteries